search

Active clinical trials for "Depressive Disorder"

Results 2841-2850 of 5015

Piloting a Novel, Mobile Cognitive Training Tool for Patients With Major Depressive Disorder (MDD)...

Major Depressive Disorder

To assess the efficacy of a mobile-device-deployed cognitive emotional treatment for depression (Moodify) versus an active control treatment (commercially available computer games).

Completed15 enrollment criteria

Magnetic Stimulation of the Brain in Schizophrenia or Depression

SchizophreniaDepression2 more

The primary objective is to evaluate if repetitive transcranial magnetic stimulation (rTMS) with theta burst frequency over dorsomedial prefrontal cortex (DMPFC) is an effective treatment for negative symptoms (anhedonia and avolition) in schizophrenia or depression. Other objectives are to increase the understanding of the underlying neurobiology of negative symptoms and the mechanisms for the treatment effect of rTMS.

Completed11 enrollment criteria

A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants...

Depressive DisorderMajor

The primary purpose of this study is to investigate the safety and tolerability of JNJ 54175446 in participants with Major Depressive Disorder (MDD).

Completed10 enrollment criteria

A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major...

Depressive DisorderMajor

This study will evaluate the efficacy, safety and tolerability of rapastinel 450 milligrams (mg) intravenous (IV) once weekly or once every 2 weeks versus placebo as an adjunctive treatment to ongoing anti-depressive therapy (ADT) in the prevention of relapse in participants with Major Depressive Disorder (MDD).

Completed14 enrollment criteria

Burst Suppression Anesthesia for Treatment of Severe Depression

Major Depressive Disorder

This study is designed to determine if the antidepressant effects of deep anesthesia via propofol are related to EEG burst suppression.

Completed17 enrollment criteria

Cognitive Therapy to Sustain the Antidepressant Effects of Intravenous Ketamine in Treatment-resistant...

Depressive DisorderMajor

The goals of this study are: 1) to investigate the efficacy of combining ketamine with intensive cognitive behavioral therapy (CBT) to sustain the antidepressant effects of ketamine; and 2) to determine ketamine's delayed effects on learning and memory, and to explore the relationship between any ketamine-induced changes in learning and memory and duration of antidepressant efficacy, with and without CBT augmentation. Subjects with a diagnosis of MDD who are treatment-resistant to at least 2 antidepressants and have chosen to pursue clinical ketamine treatment at Yale Psychiatric Hospital will be recruited for the study.

Completed12 enrollment criteria

Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression (SAINT-TRD)...

Treatment Resistant Depression

This study evaluates an accelerated schedule of theta-burst stimulation using a transcranial magnetic stimulation device for treatment-resistant depression. In a double-blind fashion, half the participants will receive accelerated theta-burst stimulation while half will receive sham treatment.

Completed40 enrollment criteria

Thrive Care: Internet CBT for Depression

Depression

This project will study the effectiveness of computerized cognitive behavioral therapy (CBT) in reducing depression symptoms. The design is a two-arm randomized controlled trial comparing (i) control arm, which is treatment as usual with (ii) treatment arm, which is treatment as usual plus computerized CBT. The primary outcome measure is change in depression symptom severity. The name of the computerized CBT program to be used in the study is Thrive.

Completed5 enrollment criteria

A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT®™ With Lidocaine for Dynamic Radial Cheek...

Cheek Line Depressions

This study will evaluate the effectiveness of Juvéderm® VOLIFT®™ with Lidocaine for dynamic radial cheek line skin depressions.

Completed5 enrollment criteria

Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder

Major Depressive Disorder

The purpose of this study is to determine the effectiveness of treatment with vortioxetine on participant goal achievement after a change in antidepressant medication for the treatment of major depressive disorder (MDD).

Completed21 enrollment criteria
1...284285286...502

Need Help? Contact our team!


We'll reach out to this number within 24 hrs